Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may be grounds for compensation. Our lawyers are working hard to acquire those hurt by the drug the compensation they may be entitled to.<br><br> <br><br> Although bleeding can be a common complication associated with anticoagulants, it has been alleged that Xarelto is much more dangerous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, in the occasion of an emergency, individuals may possibly be at danger for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> Should you or possibly a loved one suffered a serious bleeding occasion right after taking Xarelto, you might have legal recourse. For more information, contact us right now to have your case reviewed, free of charge of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral costs. In addition, they may be looking for punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.<br><br> Why Are Lawsuits Becoming Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a safe anticoagulant option.<br><br> Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.<br><br> Users of Xarelto were xareltolegalline.bitbucket.org - http://xareltolegalline.bitbucket.org/categories/Pennsylvania/Xarelto-Gi-Bleed-Old-Forge-PA-18518.html not adequately warned of the health risks of suffering a fatal bleeding event.<br><br> Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.<br><br> <br><br> Visit this page for more details on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation Trial Dates - http://Www.Travelpod.com/s/Trial%20Dates Set<br><br> <br><br> The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.